search
Back to results

Behavioral Economic Incentives and Cancer Health Risk Assessment

Primary Purpose

Cancer of the Colon

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
No incentive
Incentive
Sponsored by
University of Pennsylvania
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Cancer of the Colon

Eligibility Criteria

50 Years - 64 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion criteria:

  • male and female UPHS employees between the ages 50-64
  • those who live within 30 miles of the main endoscopy sites

Exclusion criteria:

-minimal exclusion criteria

Sites / Locations

  • University of Pennsylvania Health System

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

No incentive

Incentive

Arm Description

Colon cancer risk assessment and direct access colonoscopy scheduling for those that are eligible.

Loss-framed incentive to participate in risk assessment and additional unconditional pro-social incentive to complete colorectal cancer screening.

Outcomes

Primary Outcome Measures

Colonoscopy participation
The percent of participants who complete screening colonoscopy

Secondary Outcome Measures

Colonoscopy scheduling
The percent of participants who schedule screening colonoscopy
Risk assessment completion
The percent of participants who complete risk assessment

Full Information

First Posted
February 24, 2017
Last Updated
February 19, 2019
Sponsor
University of Pennsylvania
Collaborators
National Center for Advancing Translational Sciences (NCATS)
search

1. Study Identification

Unique Protocol Identification Number
NCT03068052
Brief Title
Behavioral Economic Incentives and Cancer Health Risk Assessment
Official Title
Behavioral Economic Incentives and Cancer Health Risk Assessment
Study Type
Interventional

2. Study Status

Record Verification Date
February 2019
Overall Recruitment Status
Completed
Study Start Date
May 8, 2017 (Actual)
Primary Completion Date
August 8, 2017 (Actual)
Study Completion Date
November 8, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pennsylvania
Collaborators
National Center for Advancing Translational Sciences (NCATS)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is an RCT among UPHS employees between ages 50-64 comparing no incentive and a loss-framed incentive for completing cancer health risk assessment. Those eligible will receive the phone number for direct colonoscopy scheduling, with the incentive arm receiving an additional unconditional incentive. The primary outcome is completion of screening colonoscopy. Secondary outcomes include scheduling of colonoscopy and completion of risk assessment.
Detailed Description
Colorectal cancer (CRC) is the second leading cause of cancer death in the United States. Despite effective screening and treatment strategies, screening rates remain at 59-65%. UPHS employees have similarly limited rates of CRC screening despite having awareness, access, and insurance coverage. There is a need to identify those who are not up-to-date on screening and eligible for outreach in this population. Financial incentives informed by behavioral economic principles could be used to encourage self-report about screening status and completion of CRC screening. This research utilizes a digital health platform, Way to Health, to evaluate the feasibility of a cancer health risk assessment. This is a single-center RCT among UPHS employees between ages 50-64 that will randomize eligible participants into one of two study arms: (1) no incentive to complete cancer health risk assessment (no incentive) or (2) loss-framed incentive to complete cancer health risk assessment (incentive). Those that are eligible for screening will receive a direct access phone number to schedule colonoscopy, with an additional unconditional incentive for those in incentive arm. The primary outcome is completion of screening colonoscopy, with secondary outcomes of colonoscopy scheduling and completion of risk assessment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cancer of the Colon

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
2000 (Actual)

8. Arms, Groups, and Interventions

Arm Title
No incentive
Arm Type
Active Comparator
Arm Description
Colon cancer risk assessment and direct access colonoscopy scheduling for those that are eligible.
Arm Title
Incentive
Arm Type
Experimental
Arm Description
Loss-framed incentive to participate in risk assessment and additional unconditional pro-social incentive to complete colorectal cancer screening.
Intervention Type
Behavioral
Intervention Name(s)
No incentive
Intervention Description
Each participant will receive an email describing the importance of colorectal cancer screening and that they have been selected to receive a risk assessment. They will directed to an online platform where they will be asked about age, family history, and prior screening history. Those who are eligible for screening will be offered the VIP access phone number to schedule an appointment.
Intervention Type
Behavioral
Intervention Name(s)
Incentive
Intervention Description
Each participant will receive an email describing the importance of colorectal cancer screening and that they have been selected to receive a risk assessment, for which they will received a loss-framed incentive. They will directed to an online platform where they will be asked about age, family history, and prior screening history. Those who are eligible for screening will be offered the VIP access phone number to schedule an appointment and will receive an additional unconditional pro-social incentive.
Primary Outcome Measure Information:
Title
Colonoscopy participation
Description
The percent of participants who complete screening colonoscopy
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Colonoscopy scheduling
Description
The percent of participants who schedule screening colonoscopy
Time Frame
3 months
Title
Risk assessment completion
Description
The percent of participants who complete risk assessment
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
64 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria: male and female UPHS employees between the ages 50-64 those who live within 30 miles of the main endoscopy sites Exclusion criteria: -minimal exclusion criteria
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shivan Mehta, MD
Organizational Affiliation
University of Pennsylvania
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pennsylvania Health System
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
32623005
Citation
Mehta SJ, Reitz C, Niewood T, Volpp KG, Asch DA. Effect of Behavioral Economic Incentives for Colorectal Cancer Screening in a Randomized Trial. Clin Gastroenterol Hepatol. 2021 Aug;19(8):1635-1641.e1. doi: 10.1016/j.cgh.2020.06.047. Epub 2020 Jul 2.
Results Reference
derived

Learn more about this trial

Behavioral Economic Incentives and Cancer Health Risk Assessment

We'll reach out to this number within 24 hrs